Trials / Sponsors / Acepodia Biotech, Inc.
Acepodia Biotech, Inc.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease IgG4 Related Disease | Phase 1 / Phase 2 | 2026-01-01 |
| Recruiting | ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2024-08-22 |
| Recruiting | ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL | Phase 1 | 2023-01-21 |
| Completed | ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors Locally Advanced Solid Tumor, Metastatic Cancer, Solid Tumor | Phase 1 | 2020-06-24 |